Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can closing your eyes help you walk better? new rehab trial for nerve disorder

NCT ID NCT03881930

First seen May 30, 2026 · Last updated Jun 19, 2026 · Updated 3 times

Summary

This study tests whether balance rehabilitation that changes how patients see (closing eyes, using a mask, or projecting moving dots) can improve walking stability better than standard rehab with eyes open. It includes 40 adults with chronic nerve damage who have trouble with balance. Participants will do 20 rehab sessions, and their walking will be measured right after and two months later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service de Médecine Physique et de Réadaptation (MPR)

    RECRUITING

    Paris, 75010, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

balance rehabilitation with modified visual input (eyes closed, mask, or moving dots)

What this could lead to

If it works, this could point toward a better way to improve balance and walking stability in people with nerve damage.

What could go wrong

This is a small, early-stage study with only 40 participants, so results may not apply to everyone. The intervention is non-drug and may not produce lasting benefits.

Conditions

The condition(s) this trial relates to.

Ataxia chronic inflammatory demyelinating polyradiculoneuropathy Peripheral Nervous System Diseases Somatosensory Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.